Home
People
Research
Publications
Links
Contact
Funding
RSS Feed
ARID1A and TERT promoter mutations in dedifferentiated meningioma.
Revaz Machaidze
June 1, 2015
«
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.
MALDI Mass Spectrometry Imaging Analysis of Pituitary Adenomas: Toward the Near Real-Time Delineation of Pituitary Tumors.
»
News & Events
Craniopharyngioma Trial Continues Enrollment
DRAMATIC CLINICAL RESPONSE TO PD-1 BLOCKADE IN MMR DEFICIENT HIGH-GRADE MENINGIOMA
GERMLINE AND SOMATIC BAP1 MUTATIONS IN HIGH GRADE MENINGIOMA.
HIGHLY MULTIPLEXED IMAGING OF HUMAN TISSUES
Molecular Margins with Metabolite Guide Brain Surgery
PIK3CA MUTATIONS IN MENINGIOMA
TARGETED THERAPY FOR PAPILLARY CRANIOPHARYNGIOMA
Top
